New test could improve future diagnosis and monitoring of IBD

	Ulcerative Colitis
	The latest ulcerative colitis news from News Medical

	New test could improve future diagnosis and monitoring of IBD A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests.

	Pregnant individuals with inflammatory bowel disease show heightened vaginal inflammation Pregnant individuals with inflammatory bowel disease (IBD) have higher levels of pro-inflammatory immune molecules, known as cytokines, in their vaginal mucosa than their healthy counterparts, according to a new study published January 14, 2026 in the open-access journal PLOS One by Ana Maldonado-Contreras of University of Massachusetts Chan Medical School, U.S., and colleagues.

			Research points to major healthcare access challenges faced by young adults with IBD The Crohn's & Colitis Foundation today revealed compelling new research pointing to major healthcare access challenges and financial burdens disproportionately affecting young adults with Inflammatory Bowel Disease (IBD).

			Hanson Wade Group - 4th Precision Medicine in Inflammatory Bowel Disease Summit Enhancing Biomarker Evaluation & Innovating Organoid & AI Models to Test & Validate Patient Samples to Improve Response Rate, Efficacy & Success of Inflammatory Bowel Disease Therapies

			Bowel preparation for colonoscopies may temporarily alter gut balance, preclinical study suggests New preclinical research suggests that bowel preparation procedures for colonoscopies may temporarily alter gut balance, culminating in unappreciated effects in patients with compromised gastrointestinal health.

	Blood test opens the doors to early diagnosis and prevention of Crohn's disease Sinai Health researchers have shown a blood test that can predict Crohn's disease years before symptoms appear, opening the doors to early diagnosis and potentially prevention.

	Short-term, calorie-restrictive diet improves Crohn’s disease symptoms A Stanford Medicine-led study finds a short-term, calorie-restrictive diet significantly improved symptoms.

	Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, has announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ENV-6946.

	Exposure to micro- and nanoplastics linked to rising number of people with chronic IBD A research team led by the Medical University of Vienna and the University of Vienna has investigated a possible link between the rising number of people with chronic inflammatory bowel disease and the increasing exposure to micro- and nanoplastics (MNPs).

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026